A practical synthesis of nonpeptide cyclic ureas as potent HIV protease inhibitors

被引：0
|
作者：
Rossano, L. T.
Lo, Y. S.
Anzalone, L.
Lee, Y.-C.
机构：
来源：
Tetrahedron Letters | / 36卷 / 28期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] NONPEPTIDE HIV PROTEASE INHIBITORS DESIGNED TO REPLACE A BOUND WATER
    CHENERA, B
    DESJARLAIS, RL
    FINKELSTEIN, JA
    EGGLESTON, DS
    MEEK, TD
    TOMASZEK, TA
    DREYER, GB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (12) : 2717 - 2722
  • [32] Cyclic HIV protease inhibitors:: Design and synthesis of orally bioavailable, pyrazole P2/P2′ cyclic ureas with improved potency
    Han, Q
    Chang, CH
    Li, RH
    Ru, Y
    Jadhav, PK
    Lam, PYS
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2019 - 2028
  • [33] Flexible docking, synthesis and biological evaluation of N-[(4-pyrazolyl)cyclopropylmethyl] cyclic ureas as HIV protease inhibitors.
    Han, W
    Hu, ZL
    Pelletier, J
    Rossi, KA
    Hodge, CN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U868 - U868
  • [34] Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton
    Miyachi, H
    Kato, M
    Kato, F
    Hashimoto, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) : 263 - 265
  • [35] Synthesis of highly potent HIV protease inhibitors with activity against protease resistant virus.
    Lu, ZJ
    Raghavan, S
    Charest, M
    Stahlhut, MW
    Rutkowski, CA
    Himmelberger, AL
    Olsen, DB
    Schleif, WA
    Carella, A
    Gabryelski, L
    Jin, LX
    Lin, JH
    Tata, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U9 - U9
  • [36] SYNTHESIS, STRUCTURE-ACTIVITY RELATIONSHIP AND X-RAY STUDIES OF POTENT NONPEPTIDAL CYCLIC HIV PROTEASE INHIBITORS
    RU, Y
    LAM, PYS
    HODGE, CN
    JADHAV, PK
    ALDRICH, PE
    EYERMANN, CJ
    RAYNER, MM
    MEEK, JL
    OTTO, MJ
    CHANG, CH
    WEBER, PC
    ERICKSONVIITANEN, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 36 - MEDI
  • [37] Structure activity relationship of cyclic ureas with asymmetric P2/P2' substituents: Potent inhibitors of HIV-1 protease.
    DeLucca, GV
    Kim, UT
    Akamike, E
    Lam, P
    Clark, C
    Rodgers, J
    Wang, HS
    Ko, S
    Srivastava, A
    Tanabe, K
    Klabe, R
    Beverly
    Bacheler, L
    EricksonViitanen, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 306 - MEDI
  • [38] Interpreting trends in the binding of cyclic ureas to HIV-1 protease
    Mardis, KL
    Luo, R
    Gilson, MK
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 309 (02) : 507 - 517
  • [39] A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994)
    WONG, YN
    BURCHAM, DL
    SAXTON, PL
    ERICKSONVIITANEN, S
    GRUBB, MF
    QUON, CY
    HUANG, SM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (02) : R2 - R2
  • [40] DESIGN AND SYNTHESIS OF POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS
    KALDOR, SW
    KALISH, V
    DRESSMAN, BA
    FRITZ, JE
    HAMMOND, M
    CROWELL, TA
    TATLOCK, J
    REICH, S
    DAVIES, J
    APPELT, K
    SHETTY, B
    SU, KS
    CAMPANALE, KM
    BURGESS, JA
    LUBBENHUSEN, PP
    BAXTER, AJ
    MUESING, MA
    HATCH, SD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 17 - MEDI
12345